ATLASVeradermics (MANE) earnings date: Nov 10, 2026
Veradermics (MANE) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 10, 2026. Analysts expect EPS of -$0.59.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MANE
| Last price | $139.69 (-2.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.2% |
These figures come from the same calibrated model and valuation as the Veradermics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Veradermics reports on Nov 10, 2026. One email the day before, with ATLAS’s read on Veradermics. You can switch it off at any time.
Alert me before MANE reportsFree to start. Creating an account takes under a minute.
MANE earnings at a glance
| Next report (confirmed) | Tue, Nov 10, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.59 |
| Last report | Aug 11, 2026 · Beat |
| Average EPS surprise | -231.9% |
| Sector | Healthcare · Biotechnology |
Veradermics earnings history: last 2 reports
Veradermics last reported on Aug 11, 2026: EPS of -$0.58 against an estimate of -$0.64 (+9.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.64 | -$0.58 | +9.4% | Beat | -1.5% |
| Mar 30, 2026 | -$18.24 | -$104.54 | -473.1% | Miss | -3.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MANE
See the fair value, the probability range and the earnings history of Veradermics on its ATLAS page.
Veradermics (MANE) stock analysisPlans from €3.99 a month.
Veradermics earnings: frequently asked questions
When does Veradermics (MANE) report earnings?
Veradermics is scheduled to report on Tuesday, November 10, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for MANE?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.59 per share (USD). Estimates can change before the report.
Did Veradermics beat earnings estimates last quarter?
Veradermics last reported on Aug 11, 2026: EPS of -$0.58 against an estimate of -$0.64 (+9.4% surprise), a beat.
How much does MANE usually move in a day?
On a normal trading day the ATLAS model puts MANE’s one-day range at about ±4.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 10, 2026
Educational information, not investment advice. Disclaimer